Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022

SELL
$221.42 - $260.97 $209,241 - $246,616
-945 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$177.01 - $223.45 $167,274 - $211,160
945 New
945 $208,000
Q3 2021

Nov 10, 2021

SELL
$181.39 - $202.99 $185,380 - $207,455
-1,022 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$187.49 - $221.1 $191,614 - $225,964
1,022 New
1,022 $220,000
Q3 2018

Nov 13, 2018

SELL
$167.73 - $192.74 $49,480 - $56,858
-295 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$151.6 - $177.13 $72,010 - $84,136
-475 Reduced 61.69%
295 $48,000
Q4 2017

Feb 12, 2018

BUY
$137.28 - $155.55 $105,705 - $119,773
770
770 $115,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Blackhawk Capital Partners Llc. Portfolio

Follow Blackhawk Capital Partners Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackhawk Capital Partners Llc., based on Form 13F filings with the SEC.

News

Stay updated on Blackhawk Capital Partners Llc. with notifications on news.